BellBrook Labs and BMG Labtech to Offer Webinar on Integrated Platform for Screening Kinases and Methyltransferases

Sourcing, assembling and testing all of the required components to screen enzyme drug targets such as kinases and methyltransferases is costly and time consuming. In this free webinar, we will describe how to skip much of the up front reagent testing and assay development and begin screening or profiling kinases and methyltransferases immediately using BellBrook's Transcreener HTS Assays with pre-calibrated enzymes and BMG's Pherastar Plus reader.

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInEmail a friend

Madison WI (PRWEB) May 10, 2013

Join us for a webinar on May 15, 2013 at 12:00 PM EDT.

An Integrated instrument-Reagent Platform for Screening and Profiling Kinases and Methyltransferases

Register now! https://attendee.gotowebinar.com/register/5177117919789326592

Biochemical HTS assays are a critical component of drug discovery programs focused on enzyme targets like kinases and methyltransferases. Assembling high quality assay reagents and validating them on a detection platform that can deliver speed, accuracy and reproducibility can consume a significant amount of time and resources. The shift toward screening focused libraries against multiple targets in parallel can add to the assay development burden substantially.

In this webinar, you will learn:

  • How Transcreener HTS Assays allow robust, initial velocity detection of any kinase or methyltransferase enzyme.
  • How to sync Transcreener assays with BMG’s Pherastar Plus plate reader to generate high quality screening or profiling data.
  • How to use Pherastar’s onboard software to determine IC50 values directly from raw assay data without constructing a standard curve.
  • How to eliminate costly biochemical assay development using turnkey kits combining Transcreener assays and pre-calibrated kinase and methyltransferase enzymes and substrates.

Participants should come away confident that they can apply a robust, cost-effective, user friendly solution to immediately begin screening/profiling multiple kinases or methyltransferases in parallel.

After registering, you will receive a confirmation email containing information about joining the webinar.

About BellBrook Labs. BellBrook Labs is dedicated to accelerating drug discovery and biological research by providing innovative high throughput screening solutions for enzymes and phenotypic assays. The company’s Transcreener® HTS enzyme assays, used by all of the major pharmaceutical companies, make it easy to screen thousands of different enzymes, including validated targets like kinases, as well as emerging targets like ATPases, GTPases, methyltransferases, and glycosyltransferases. The iuvo™ Microconduit Array technology and assay screening service is a line of unique microscale devices for miniaturization and automation of advanced cell models that are more representative of human physiology.

About BMG LABTECH. BMG LABTECH is ‘The Microplate Company’. Since we are committed to producing microplate readers you can be assured that we will provide you with the best detection that German engineering can provide. The PHERAstar line of microplate readers are our top of the line multi-functional readers for high-throughput screening; providing you with high sensitivity and fast read-times in all detection modes. The PHERAstar employs assay specific optic modules that have been optimized to perform well whether your test detects fluorescence intensity, fluorescence polarization, time-resolved FRET or many other detection modes.

For more information about the variety of microplate readers that BMG LABTECH offers, please visit our website: http://www.bmglabtech.com.


Contact